As political parties in the UK prepare their campaigns for the December general election, the health secretary, Matt Hancock, has again insisted that neither the National Health Service nor higher UK drug prices will be on the agenda of negotiations on a post-Brexit free trade deal with the US.
A television program aired on Channel 4 on 28 October claimed that senior UK civil servants had covered the possibility of higher NHS drug prices at six separate meetings with US pharmaceutical firms, as part of preparations for negotiations on a UK-US